Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Meds
| Question | Answer |
|---|---|
| mon·te·lu·kast [mon'-t@-LOO-kast] Brand? | Singulair |
| leu·ko·tri·ene [loo'-kuh-TRI-een] | A lipid produced by white blood cells in an immune response to antigens, that contributes to allergic asthma and inflammatory reactions. Related to prostaglandins. [leuko(cyte) + triene, a compound containing three double bonds (tri- + -ene).] |
| mon·te·lu·kast [mon'-t@-LOO-kast] ADT dose | ADT - 10mg tab PO |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] How supplied | Tablets (film-coated): 10 mg Tablets (chewable): 5 mg |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] Indications | For prophylaxis and long-term treatment of asthma |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] dosage | Adults and children ages 15 and older: 10 mg (film-coated tablet) P.O. once daily in evening. Children ages 6 to 14: 5 mg (chewable tablet) P.O. once daily in evening. |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] Adverse reactions | CNS: HEADACHE, dizziness, fatigue, asthenia. EENT: nasal congestion, dental pain. GI: dyspepsia, infectious gastroenteritis, abdominal pain. GU: pyuria. Hepatic: increased ALT and AST levels. Respiratory: cough. Skin: rash. |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] Drug interactions | Drug-drug. Phenobarbital, rifampin: may decrease bioavailability of montelukast because of induction of hepatic metabolism. Monitor closely. |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] Nursing considerations (1/5) | Use cautiously and with appropriate monitoring in patients whose dosages of systemic corticosteroids are reduced. |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] Nursing considerations (4/5) | Alert: Although dose of inhaled corticosteroids may be reduced gradually, don't abruptly substitute drug for inhaled or oral corticosteroids. |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] Nursing considerations (5/5) | Drug isn't indicated for use in patients with acute asthmatic attacks, status asthmaticus, or as monotherapy for management of exercise-induced bronchospasm. Appropriate rescue drug should be continued for acute exacerbations. |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] Nursing considerations (2/5) | Assess patient's underlying condition and monitor for effectiveness. |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] Nursing considerations (3/5) | Safety and efficacy for patients under age 6 haven't been established. |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] Patient teaching (1/6) | Advise patient to take drug daily, even if asymptomatic, and to contact doctor if asthma isn't well controlled. |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] Patient teaching (2/6) | Warn patient not to reduce or stop taking other prescribed antiasthma drugs without doctor's approval. |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] Patient teaching (3/6) | Advise patient to seek medical attention if short-acting inhaled bronchodilators are needed more often than usual during drug therapy. |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] Patient teaching (4/6) | Warn patient that drug isn't beneficial in acute asthma attacks or in exercise-induced bronchospasm, and advise him to keep appropriate rescue drugs available. |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] Patient teaching (5/6) | Advise patient with known aspirin sensitivity to continue to avoid using aspirin and NSAIDs during drug therapy. |
| montelukast sodium - Singulair mon·te·lu·kast [mon'-t@-LOO-kast] Patient teaching (6/6) | Advise patient with phenylketonuria that chewable tablet contains phenylalanine. |
| montelukast sodium - Singulair Pregnancy Risk | Category B |
| acyclovir - Acyclo-V, Zovirax Pregnancy Risk | Category C |
| acyclovir - Acyclo-V, Zovirax How supplied | Ointment: 5% |
| acyclovir - Acyclo-V, Zovirax Action | Inhibits herpes simplex and varicella-zoster viral DNA synthesis by inhibiting viral DNA polymerase action. |
| acyclovir - Acyclo-V, Zovirax Indications | Initial herpes genitalis; limited, non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients |
| acyclovir - Acyclo-V, Zovirax dosage | Adults: cover all lesions q 3 hours six times daily for 7 days. Although dose varies depending on total lesion area, use about 1/4-inch (1.3-cm) ribbon of ointment on each 4-inch (10-cm) square of surface area. |
| acyclovir - Acyclo-V, Zovirax Adverse reactions | Skin: transient burning and stinging, rash, pruritus, vulvitis; edema, pain at application site. |
| acyclovir - Acyclo-V, Zovirax Nursing considerations (1/5) | Start therapy as early as possible after onset of symptoms, as ordered. |
| acyclovir - Acyclo-V, Zovirax Nursing considerations (2/5) | Apply drug with a finger cot or rubber glove to prevent autoinoculation of other body sites and transmission of infection to other persons. |
| acyclovir - Acyclo-V, Zovirax Nursing considerations (3/5) | All lesions must be thoroughly covered. |
| acyclovir - Acyclo-V, Zovirax Nursing considerations (4/5) | Drug is for cutaneous use only; don't apply to eye. |
| acyclovir - Acyclo-V, Zovirax Nursing considerations (5/5) | Drug isn't a cure, but it will help with symptoms. |
| acyclovir - Acyclo-V, Zovirax Patient teaching (1/6) | Teach patient that virus transmission can occur during treatment. |
| acyclovir - Acyclo-V, Zovirax Patient teaching (2/6) | Tell patient that there may be some discomfort with application. |
| acyclovir - Acyclo-V, Zovirax Patient teaching (3/6) | Stress importance of compliance for successful therapy. |
| acyclovir - Acyclo-V, Zovirax Patient teaching (4/6) | Teach patient that therapy should begin as soon as signs and symptoms appear. |
| acyclovir - Acyclo-V, Zovirax Patient teaching (5/6) | Tell patient to notify doctor if adverse reactions occur. |
| acyclovir - Acyclo-V, Zovirax Patient teaching (6/6) | Instruct patient to store drug in a dry place at 59° to 77° F (15° to 25° C). |
| acyclovir - Acyclo-V, Zovirax | (blank) |
| acyclovir - Acyclo-V, Zovirax | (blank) |
| a·cy·clo·vir [ey-sahy"-kloh-veer, -kluh-] brand names | Acyclo-V, Zovirax |
| a·cy·clo·vir [ey-sahy"-kloh-veer, -kluh-] description | an oral antiviral drug (trade name Zovirax) used to treat genital herpes; does not cure the disease but relieves the symptoms |
Created by:
AJJAD